Skip to content

Effect of Telemedecine on Post -Trauma Pain Medication Adherence .

Effect of Telemedecine on Post-trauma Pain Medication Adherence After Discharge From Emergency Departement

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05149417
Enrollment
1350
Registered
2021-12-08
Start date
2020-08-21
Completion date
2022-07-31
Last updated
2022-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-traumatic Pain

Keywords

Telemedecine, Adherence, post- traumatic pain

Brief summary

The impact of telemonitoring on patients' adherence to post trauma pain treatment , their satisfaction and pain relief after discharge from the ED.

Detailed description

This is a prospective, multicenter, randomized trial . Participants are recruited from the emergency departement of Fattouma Bourguiba Monastir. This study is a seven day three-arm parallel group trial . Participants inculded are aged more than 16 years old who presented to the ED for minor trauma and discharged with analgesic treatment. They are randomized to one of two trial TM intervention groups (SMS and TM) or usual care group (control) in a 1 :1 :1 allocation ratio. For all inculded patients, demographic characteristics were collected as well as clinical examination findings. The interventional care provided at the ED was mentioned. At ED discharge the pain Visual Analogue Scale (VAS) was evaluated and the analgesic treatment prescribed was noted.

Interventions

OTHERSMS reminding

patients received SMS at day 2 , day 4 and day 7 after emergency departement discharge to remind them to take their treatment .

OTHERtelemonitoring

Patients received a phone call on day 2 and day 4 to evaluate the adherence , to detect any problem that can affect the adherence to the treatment and modify the analgesic protocol treatment if needed.

Sponsors

University of Monastir
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Included patients were randomized to one of the 3 groups: 1. Usual care (control) group Patients enrolled in this group were discharged and they didn't undergo any intervention within the treatment period. 2. SMS group Or short message service (SMS) group: patients received SMS at day 2 every day to remind them to take their treatment . 3. Telemonitoring group: Patients received a phone call on day 2 and day 4 to evaluate the adherence , to detect any problem that can affect the adherence to the treatment and modify the analgesic protocol treatment if needed according to an algorithm: At each call (day 2 and day 4), the VAS was assessed. If VAS ≥ 3 we looked for a medication discontinuation, inadequate dose or change of the prescribed treatment and the patient was instructed to take action accordingly . If the problem is related to side effects, the analgesic treatment was changed or associated to another analgesic

Eligibility

Sex/Gender
ALL
Age
16 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* Age \>16 years old with minor trauma and discharged with an analgesic treatment. * Included patients should have regular access to a mobile phone ,were able to interact with SMS or could do so with help of a relative. * Patients who accepted to participate to the study. * No contraindication to analgesic medication

Exclusion criteria

* Swallowing disorder or inability to swallow. * Unsuitable for follow-up.

Design outcomes

Primary

MeasureTime frameDescription
Visual analog scale after 7 days of follow-upat seven day after ED discharge .Patient's adherence to analgesics treatment which was assessed by calling patients or by sending SMS in day 2, day 4,and day 7 in SMS group and the telemonitoring group respectively.

Secondary

MeasureTime frameDescription
Likert scaleat seven day post ED discharge .Patients' satisfaction which was assessed through likert scale. minimum=1(strongly disagree) , maximum=5 (strongly agree)

Countries

Tunisia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026